{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:57:46Z","timestamp":1770710266754,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ctrv.2011.10.006","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T04:20:08Z","timestamp":1321935608000},"page":"605-612","source":"Crossref","is-referenced-by-count":71,"title":["Diffuse malignant peritoneal mesothelioma \u2013 An update on treatment"],"prefix":"10.1016","volume":"38","author":[{"given":"Peyman","family":"Mirarabshahii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence C.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Pourgholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0005","first-page":"32","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda","year":"2007","journal-title":"Med Gen Med"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10147-008-0839-2","article-title":"Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma","volume":"14","author":"Tanida","year":"2009","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0015","first-page":"673","article-title":"Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis","volume":"111","author":"Scripcariu","year":"2007","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.ctrv.2011.10.006_b0020","doi-asserted-by":"crossref","unstructured":"Souza FF, Jagganathan J, Ramayia N, Johnston C, Jackman D, Abbeele AV, Ros PR. Recurrent malignant peritoneal mesothelioma: radiological manifestations. Abdom Imaging 2009 Mar 25.","DOI":"10.1007\/s00261-009-9512-0"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2011.10.006_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1445-1433.2001.02239.x","article-title":"Aggressive multimodality treatment for primary malignant peritoneal mesothelioma","volume":"71","author":"Teoh","year":"2001","journal-title":"ANZ J Surg"},{"issue":"12","key":"10.1016\/j.ctrv.2011.10.006_b0040","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/bjs.5377","article-title":"Sex difference in diffuse malignant peritoneal mesothelioma","volume":"93","author":"Yan","year":"2006","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0045","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini Vde","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0050","doi-asserted-by":"crossref","unstructured":"Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28(2):583-607; quiz 21\u20132.","DOI":"10.1148\/rg.282075175"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-2197.2006.03579.x","article-title":"Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy","volume":"76","author":"Hadi","year":"2006","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ctrv.2011.10.006_b0060","doi-asserted-by":"crossref","unstructured":"Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009;99(2):109\u201313.","DOI":"10.1002\/jso.21177"},{"key":"10.1016\/j.ctrv.2011.10.006_b0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-6-289","article-title":"Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report","volume":"6","author":"Fasola","year":"2006","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2036.2009.04050.x","article-title":"Occupational asbestos exposure and digestive cancers \u2013 a cohort study","volume":"30","author":"Clin","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0080","first-page":"59","article-title":"Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management","volume":"52","author":"Chua","year":"2009","journal-title":"Can J Surg"},{"key":"10.1016\/j.ctrv.2011.10.006_b0085","doi-asserted-by":"crossref","unstructured":"Davidson B. New diagnostic and molecular characteristics of malignant mesothelioma. Ultrastruct Pathol. 2008;32(6):227\u201340.","DOI":"10.1080\/01913120802454298"},{"issue":"5","key":"10.1016\/j.ctrv.2011.10.006_b0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"issue":"64","key":"10.1016\/j.ctrv.2011.10.006_b0095","first-page":"1087","article-title":"Localized visceral invasion of peritoneal mesothelioma causing intestinal obstruction: a new clinical presentation","volume":"52","author":"Sethna","year":"2005","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1440-1827.2009.02387.x","article-title":"Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac","volume":"59","author":"Serio","year":"2009","journal-title":"Pathol Int"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1600-0560.2008.01094.x","article-title":"Peritoneal mesothelioma presenting as a skin nodule","volume":"36","author":"Abban","year":"2009","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02893422","article-title":"Subcutaneous metastasis of peritoneal mesothelioma diagnosed by fine-needle aspiration","volume":"12","author":"Pappa","year":"2006","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030089160509100101","article-title":"Malignant peritoneal mesothelioma","volume":"91","author":"de Pangher Manzini","year":"2005","journal-title":"Tumori"},{"issue":"8","key":"10.1016\/j.ctrv.2011.10.006_b0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Comin","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1245\/s10434-006-9192-8","article-title":"Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1827.2009.02344.x","article-title":"Establishment of novel mAb to human ERC\/mesothelin useful for study and diagnosis of ERC\/mesothelin-expressing cancers","volume":"59","author":"Ishikawa","year":"2009","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.ctrv.2011.10.006_b0135","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-07-1613","article-title":"Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC\/mesothelin increases its potential as a useful serum tumor marker for mesothelioma","volume":"14","author":"Shiomi","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cncy.20036","article-title":"Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma","volume":"117","author":"Factor","year":"2009","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ctrv.2011.10.006_b0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thx.2006.068114","article-title":"Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma","volume":"62","author":"Creaney","year":"2007","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0155","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/DV1JYBL8LLYYT4J5","article-title":"Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one institution, including post-intraperitoneal hyperthermic chemotherapy findings","volume":"128","author":"Patel","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0160","doi-asserted-by":"crossref","unstructured":"Husain AN, Colby TV, Ord\u00c33\u00c3\u00b1ez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 2009;133(8):1317\u20131331.","DOI":"10.5858\/133.8.1317"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bjs.7263","article-title":"Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma","volume":"98","author":"Chua","year":"2011","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0170","first-page":"677","article-title":"A case of omental mesothelioma presenting with laminar thickening of omentum-appearances of diffuse malignant peritoneal mesothelioma","volume":"35","author":"Takeuchi","year":"2008","journal-title":"Gan To Kagaku Ryoho"},{"issue":"9","key":"10.1016\/j.ctrv.2011.10.006_b0175","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","article-title":"Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0180","unstructured":"Muensterer OJ, Averbach AM, Jacquet P, Otero SE, Sugarbaker PH. Malignant peritoneal mesothelioma. Case-report demonstrating pitfalls of diagnostic laparoscopy. Int Surg 1997;82(3):240\u2013243."},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","article-title":"Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0190","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon\u2019s role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ctrv.2011.10.006_b0195","doi-asserted-by":"crossref","unstructured":"Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer. 2011;117(9):1855\u20131863.","DOI":"10.1002\/cncr.25640"},{"key":"10.1016\/j.ctrv.2011.10.006_b0200","doi-asserted-by":"crossref","unstructured":"Chua TC, Yan TD, Deraco M, Glehen O, Moran BJ, Sugarbaker PH. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. The British journal of surgery [Multicenter Study]. 2011;98(1):60\u201364.","DOI":"10.1002\/bjs.7263"},{"key":"10.1016\/j.ctrv.2011.10.006_b0205","doi-asserted-by":"crossref","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol [Multicenter Study]. 2009 20;27(36):6237\u20136242.","DOI":"10.1200\/JCO.2009.23.9640"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0210","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0215","doi-asserted-by":"crossref","unstructured":"Stewart JHt, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies. Expert Rev Anticancer Ther [Review]. 2008;8(11):1809\u20131818.","DOI":"10.1586\/14737140.8.11.1809"},{"key":"10.1016\/j.ctrv.2011.10.006_b0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4613-1247-5_15","article-title":"Peritonectomy procedures","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","article-title":"Lymph node metastases in diffuse malignant peritoneal mesothelioma","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0235","unstructured":"Laterza B, Kusamura S, Baratti D, Oliva GD, Deraco M. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 2009;23(1):187\u2013190."},{"issue":"5","key":"10.1016\/j.ctrv.2011.10.006_b0240","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02656730701455318","article-title":"Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy","volume":"23","author":"Sugarbaker","year":"2007","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ctrv.2011.10.006_b0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-4-17","article-title":"Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy","volume":"4","author":"Yan","year":"2006","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/ejso.2001.1152","article-title":"Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma","volume":"28","author":"Begossi","year":"2002","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jso.20370","article-title":"An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution","volume":"92","author":"Sugarbaker","year":"2005","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COC.0b013e3180684181","article-title":"Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma","volume":"31","author":"Hesdorffer","year":"2008","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2011.10.006_b0265","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3748\/wjg.14.1159","article-title":"Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis","volume":"14","author":"Al-Shammaa","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2009.24.8500","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient?","volume":"28","author":"Khatri","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0009-739X(07)71268-X","article-title":"Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia","volume":"81","author":"Gomez Portilla","year":"2007","journal-title":"Cir Esp"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0280","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/lap.2008.0392","article-title":"Combined laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal mesothelioma","volume":"19","author":"Esquivel","year":"2009","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"5","key":"10.1016\/j.ctrv.2011.10.006_b0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00280-008-0800-0","article-title":"A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin","volume":"63","author":"Van der Speeten","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/sonc.2002.30236","article-title":"Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience","volume":"29","author":"Sugarbaker","year":"2002","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2011.10.006_b0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11864-002-0003-6","article-title":"Peritoneal mesothelioma","volume":"3","author":"Mohamed","year":"2002","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0300","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","article-title":"Comprehensive management of diffuse malignant peritoneal mesothelioma","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2011.10.006_b0305","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0399-8320(07)73963-5","article-title":"Local-regional approach to diffuse malignant peritoneal mesothelioma","volume":"31","author":"Sugarbaker","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"issue":"11","key":"10.1016\/j.ctrv.2011.10.006_b0310","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","article-title":"Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma","volume":"130","author":"Cerruto","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/ejso.2001.1044","article-title":"Peritoneal mesothelioma proposal for a staging system","volume":"27","author":"Sebbag","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2011.10.006_b0320","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1245\/s10434-009-0611-5","article-title":"The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome","volume":"16","author":"Brouquet","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2011.10.006_b0325","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2000.01571.x","article-title":"Results of treatment of 33 patients with peritoneal mesothelioma","volume":"87","author":"Sebbag","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctrv.2011.10.006_b0330","doi-asserted-by":"crossref","unstructured":"Chua TC, Liauw W, Morris DL. New treatments and outcomes in peritoneal carcinomatosis. Med J Aust. 2009 Jul 6;191(1):3\u20134.","DOI":"10.5694\/j.1326-5377.2009.tb02662.x"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0335","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0340","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","article-title":"Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2013a prospective study of 70 consecutive cases","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0345","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12253-009-9170-0","article-title":"Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma","volume":"15","author":"Chua","year":"2009","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14728214.12.1.127","article-title":"Emerging drugs for mesothelioma","volume":"12","author":"Scagliotti","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.ctrv.2011.10.006_b0355","doi-asserted-by":"crossref","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma [see comment]. J Clin Oncol 2003;21(14):2636\u20132644.","DOI":"10.1200\/JCO.2003.11.136"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2011.10.006_b0365","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma \u2013 results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Cancer"},{"issue":"21","key":"10.1016\/j.ctrv.2011.10.006_b0370","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0375","first-page":"475","article-title":"A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)","volume":"36","author":"Kusama","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/030089161109700105","article-title":"Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience","volume":"97","author":"Lainakis","year":"2011","journal-title":"Tumori"},{"issue":"10","key":"10.1016\/j.ctrv.2011.10.006_b0385","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/01.cad.0000236309.66080.3b","article-title":"Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis","volume":"17","author":"Molucon-Chabrot","year":"2006","journal-title":"Anticancer Drugs"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0390","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLE.0b013e318173a61e","article-title":"Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy","volume":"18","author":"Patriti","year":"2008","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0395","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2011.10.006_b0400","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/ejso.2000.0983","article-title":"Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model","volume":"26","author":"Pestieau","year":"2000","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2011.10.006_b0405","first-page":"322","article-title":"Impressive remission of locally advanced malignant peritoneal mesothelioma treated with combination of radiotherapy and intraperitoneal paclitaxel","volume":"28","author":"Takeuchi","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"issue":"20 Pt 1","key":"10.1016\/j.ctrv.2011.10.006_b0410","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1158\/1078-0432.CCR-06-1056","article-title":"Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma","volume":"12","author":"Spugnini","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ctrv.2011.10.006_b0415","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/annonc\/mdl060","article-title":"Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference","volume":"17","author":"Hassan","year":"2006","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2011.10.006_b0420","first-page":"453","article-title":"Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma","volume":"29","author":"Zaffaroni","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ctrv.2011.10.006_b0425","unstructured":"Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, Jablons DM. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther. 2002;1(9):687\u2013694."},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0430","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.ctrv.2011.10.006_b0435","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1158\/1078-0432.CCR-09-0062","article-title":"Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P","volume":"15","author":"Kreitman","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ctrv.2011.10.006_b0440","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejso.2009.04.007","article-title":"Circulating CA125 and diffuse malignant peritoneal mesothelioma","volume":"35","author":"Baratti","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2011.10.006_b0445","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-010-1080-6","article-title":"Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin","volume":"17","author":"Blackham","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2011.10.006_b0450","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma","volume":"35","author":"Yano","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2011.10.006_b0455","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","article-title":"Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy","volume":"31","author":"Elias","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"10.1016\/j.ctrv.2011.10.006_b0460","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","article-title":"Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2011.10.006_b0465","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","article-title":"Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study","volume":"13","author":"Brigand","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"10.1016\/j.ctrv.2011.10.006_b0470","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737211002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737211002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T15:23:08Z","timestamp":1639754588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737211002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0305737211002210"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2011.10.006","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}